Gail M. Farfel - Sep 19, 2022 Form 4 Insider Report for ProMIS Neurosciences Inc. (PMN)

Role
Chief Executive Officer
Signature
/s/ Gail M. Farfel, by Jason L. Langford, Attorney-in-Fact
Stock symbol
PMN
Transactions as of
Sep 19, 2022
Transactions value $
$0
Form type
4
Date filed
9/20/2022, 04:57 PM
Previous filing
Jun 17, 2022
Next filing
Dec 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMN Option (right to buy) Award $0 +208K $0.00 208K Sep 19, 2022 Common Shares 208K $7.10 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Conversion or exercise price is in Canadian dollars.
F2 The option agreement provides that the option vests 25% on the one year anniversary of grant and the balance vests ratably over 36 months.